newsfilter
← Latest News
GlobeNewswire·

Zevra Therapeutics to Present at Upcoming Investor Conferences

  • Zevra Therapeutics, Inc. will have its executive leadership team present at three investor conferences in New York, NY.
  • The company will hold a fireside chat at the Cantor Global Healthcare Conference on Wednesday, September 9, 2026, at 9:10 a.m. ET.
  • A fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference is scheduled for Monday, September 14, 2026, at 5:35 p.m. ET.
  • Zevra will present at the H.C. Wainwright 28th Annual Global Investment Conference fireside chat on Tuesday, September 15, 2026, at 10:00 a.m. ET.
  • Management will be available for one-on-one meetings with registered attendees at all three events.
  • Live webcast links for the presentations will be available on the "Events & Presentations" page of the company's investor relations website.
  • Zevra is a commercial-stage company focused on rare diseases, with its lead product marketed in the U.S. for Niemann-Pick disease type C.
  • The press release includes standard forward-looking statements regarding the company's ability to advance therapies \& deliver long-term value.
  • Investor contact is Nichol Ochsner, while media inquiries should be directed to Julie Downs.